S&P 500   4,989.32 (-0.44%)
DOW   38,028.74 (+0.67%)
QQQ   416.96 (-1.52%)
AAPL   165.03 (-1.20%)
MSFT   399.52 (-1.17%)
META   484.01 (-3.55%)
GOOGL   154.03 (-1.27%)
AMZN   174.96 (-2.38%)
TSLA   149.16 (-0.51%)
NVDA   804.06 (-5.04%)
AMD   149.40 (-3.66%)
NIO   3.83 (-4.25%)
BABA   68.85 (-0.04%)
T   16.36 (+0.18%)
F   12.09 (+0.25%)
MU   107.39 (-4.06%)
GE   149.19 (-2.45%)
CGC   8.09 (+3.32%)
DIS   112.13 (-0.27%)
AMC   3.24 (+10.96%)
PFE   25.81 (+1.65%)
PYPL   62.16 (+0.10%)
XOM   120.07 (+1.31%)
S&P 500   4,989.32 (-0.44%)
DOW   38,028.74 (+0.67%)
QQQ   416.96 (-1.52%)
AAPL   165.03 (-1.20%)
MSFT   399.52 (-1.17%)
META   484.01 (-3.55%)
GOOGL   154.03 (-1.27%)
AMZN   174.96 (-2.38%)
TSLA   149.16 (-0.51%)
NVDA   804.06 (-5.04%)
AMD   149.40 (-3.66%)
NIO   3.83 (-4.25%)
BABA   68.85 (-0.04%)
T   16.36 (+0.18%)
F   12.09 (+0.25%)
MU   107.39 (-4.06%)
GE   149.19 (-2.45%)
CGC   8.09 (+3.32%)
DIS   112.13 (-0.27%)
AMC   3.24 (+10.96%)
PFE   25.81 (+1.65%)
PYPL   62.16 (+0.10%)
XOM   120.07 (+1.31%)
S&P 500   4,989.32 (-0.44%)
DOW   38,028.74 (+0.67%)
QQQ   416.96 (-1.52%)
AAPL   165.03 (-1.20%)
MSFT   399.52 (-1.17%)
META   484.01 (-3.55%)
GOOGL   154.03 (-1.27%)
AMZN   174.96 (-2.38%)
TSLA   149.16 (-0.51%)
NVDA   804.06 (-5.04%)
AMD   149.40 (-3.66%)
NIO   3.83 (-4.25%)
BABA   68.85 (-0.04%)
T   16.36 (+0.18%)
F   12.09 (+0.25%)
MU   107.39 (-4.06%)
GE   149.19 (-2.45%)
CGC   8.09 (+3.32%)
DIS   112.13 (-0.27%)
AMC   3.24 (+10.96%)
PFE   25.81 (+1.65%)
PYPL   62.16 (+0.10%)
XOM   120.07 (+1.31%)
S&P 500   4,989.32 (-0.44%)
DOW   38,028.74 (+0.67%)
QQQ   416.96 (-1.52%)
AAPL   165.03 (-1.20%)
MSFT   399.52 (-1.17%)
META   484.01 (-3.55%)
GOOGL   154.03 (-1.27%)
AMZN   174.96 (-2.38%)
TSLA   149.16 (-0.51%)
NVDA   804.06 (-5.04%)
AMD   149.40 (-3.66%)
NIO   3.83 (-4.25%)
BABA   68.85 (-0.04%)
T   16.36 (+0.18%)
F   12.09 (+0.25%)
MU   107.39 (-4.06%)
GE   149.19 (-2.45%)
CGC   8.09 (+3.32%)
DIS   112.13 (-0.27%)
AMC   3.24 (+10.96%)
PFE   25.81 (+1.65%)
PYPL   62.16 (+0.10%)
XOM   120.07 (+1.31%)
Free Trial

Axsome Therapeutics (AXSM) SEC Filings & 10K Form

→ 2024's Must-Have Guide: Master Crypto Investment Today (From Darwin) (Ad)
Free axsm Stock Alerts
$67.77
+2.05 (+3.12%)
(As of 01:33 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Recent Axsome Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
04/01/2024
5:46 PM		Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
5:14 PM		Axsome Therapeutics (Subject)
Jacobson Mark L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/01/2024
7:27 AM		Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
8:02 AM		Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
8:06 AM		Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
6:06 AM		Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
7:05 PM		Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
6:09 PM		Axsome Therapeutics (Subject)
JEFFS ROGER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
5:25 PM		Axsome Therapeutics (Issuer)
Pizzie Nick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
5:34 PM		Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
5:34 PM		Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
5:34 PM		Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
5:18 PM		Axsome Therapeutics (Issuer)
Mahony Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
5:20 PM		Axsome Therapeutics (Issuer)
TABUTEAU HERRIOT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:39 PM		Axsome Therapeutics (Issuer)
Murdock Hunter R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
7:10 AM		Axsome Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2024
6:05 AM		Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
2:46 PM		Axsome Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
Form SC 13G/A
02/14/2024
6:26 AM		Axsome Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
01/08/2024
6:10 AM		Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
6:11 AM		Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2023
3:39 PM		Axsome Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2023
6:05 AM		Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2023
7:30 PM		Axsome Therapeutics (Issuer)
Mahony Susan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/12/2023
7:33 PM		Axsome Therapeutics (Issuer)
Mahony Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2023
4:03 PM		Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/15/2023
5:30 PM		Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
5:32 PM		Axsome Therapeutics (Subject)
Coleman Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2023
6:45 AM		Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2023
7:21 AM		Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2023
7:51 PM		Axsome Therapeutics (Filer)
Form 424B5
06/26/2023
4:01 PM		Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2023
3:35 PM		Axsome Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/13/2023
4:22 PM		Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2023
5:21 PM		Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
5:22 PM		Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
5:22 PM		Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2023
6:05 AM		Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2023
4:23 PM		Axsome Therapeutics (Filer)
Form DEF 14A
04/21/2023
4:24 PM		Axsome Therapeutics (Filer)
Form ARS
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:AXSM) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
1970’s computer coder issues shocking A.I. warning
TradeSmith